2024-11-20 01:37:44
Ascletis Announces FDA Clearance of Oral RdRp Inhibitor ASC10 to Conduct a Randomized, Placebo Controlled Phase Ib Study in Mild-to-Moderate COVID-19 Patients
Corporate/ 2023-07-24
Ascletis Announces FDA Clearance of Oral...

-- ASC10 is an oral double prodrug that is rapidly and completely converted in vivo into the active metabolite ASC10-A,which is the same act...

Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of KX-826 for Treatment of Androgenetic Alopecia in the US
Corporate/ 2023-07-24
Kintor Pharma Announces Completion of Pa...

SUZHOU,China,Aug. 3,2022-- Kintor Pharmaceutical Limited ("Kintor Pharma",HKEX: 9939),a clinical-stage biotechnology company devel...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release